Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20711 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROCHLORIDE | 150mg |
Inactive Ingredients
| Ingredient Name | GlaxoSmithKline LLC |
|---|---|
| CARNAUBA WAX(R12CBM0EIZ) | |
| CYSTEINE HYDROCHLORIDE(ZT934N0X4W) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| FD&C RED NO. 40(WZB9127XOA) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| POLYSORBATE 80(6OZP39ZG8H) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
